Janney Montgomery Scott LLC Grows Stake in Ultralife Co. (NASDAQ:ULBI)

Janney Montgomery Scott LLC grew its position in Ultralife Co. (NASDAQ:ULBIFree Report) by 2.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 443,150 shares of the technology company’s stock after purchasing an additional 10,450 shares during the quarter. Janney Montgomery Scott LLC owned approximately 2.67% of Ultralife worth $4,006,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of ULBI. Empowered Funds LLC boosted its position in shares of Ultralife by 7.8% during the first quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock valued at $277,000 after buying an additional 2,275 shares during the period. Vanguard Group Inc. boosted its holdings in Ultralife by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company’s stock worth $4,545,000 after buying an additional 6,640 shares during the last quarter. Hillsdale Investment Management Inc. acquired a new stake in Ultralife in the 1st quarter valued at about $166,000. O Shaughnessy Asset Management LLC acquired a new stake in shares of Ultralife during the 1st quarter worth approximately $100,000. Finally, Quadrature Capital Ltd purchased a new stake in shares of Ultralife in the 1st quarter valued at approximately $200,000. Hedge funds and other institutional investors own 30.68% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, October 3rd.

Check Out Our Latest Research Report on Ultralife

Ultralife Stock Performance

NASDAQ:ULBI opened at $7.98 on Friday. Ultralife Co. has a 1-year low of $6.36 and a 1-year high of $13.39. The company has a debt-to-equity ratio of 0.07, a current ratio of 4.07 and a quick ratio of 2.06. The firm’s fifty day moving average price is $9.17 and its 200 day moving average price is $10.35. The firm has a market cap of $132.65 million, a price-to-earnings ratio of 13.08 and a beta of 0.98.

About Ultralife

(Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Recommended Stories

Institutional Ownership by Quarter for Ultralife (NASDAQ:ULBI)

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.